Basit öğe kaydını göster

dc.contributor.authorDuzgun, Ozgul
dc.contributor.authorOzcelik, Mehmet Faik
dc.contributor.authorOzcan, Pirilti
dc.date.accessioned2023-02-21T07:44:37Z
dc.date.available2023-02-21T07:44:37Z
dc.date.issued2022
dc.identifier.citationDuzgun O., Ozcan P., Ozcelik M. F., "Did the ERAS Protocol Improve Our Results in Locally Advanced Gastric Cancer Surgery?", JOURNAL OF PERSONALIZED MEDICINE, cilt.12, sa.10, 2022
dc.identifier.issn2075-4426
dc.identifier.othervv_1032021
dc.identifier.otherav_0c7804df-cb13-4481-a3ac-459c560bd8cd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/186067
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/0c7804df-cb13-4481-a3ac-459c560bd8cd/file
dc.identifier.urihttps://doi.org/10.3390/jpm12101549
dc.description.abstractERAS is a protocol consisting of multidisciplinary approaches, including patient education, fluid resuscitation, keeping patients' innormothermic state, early feeding, and mobilization. We aimed to present and compare the postoperative results of patients operated on due to locally advanced gastric cancer who received neoadjuvant therapy in two high-volume tertiary centers, and aimed to present that ERAS protocols can be applied with success without increasing the complication rate. This retrospective study consisted of two groups: a non-ERAS group and an ERAS group. The ERAS group consisted of 106 patients and the non-ERAS group consisted of 104 patients. The time to first flatus was shorter in the ERAS group compared with the non-ERAS group: 2.8 (1-5) and 3.5 (1-5, p = 0.008), respectively. The average stay at the hospital was 9 (7-22) days in thenon-ERAS group and 6.5 (5-14) days in the ERAS group. Readmission to the hospital within first 15 days after discharge was observed in one (%0.9) patient in the non-ERAS group and in four (%3.8) patients in the ERAS group. ERAS protocols contribute positively to the nutritional status of patients by reducing surgical stress and the rate of hospitalization, and reducing health costs. However, it appears to be associated with increased readmission rates.
dc.language.isoeng
dc.subjectTıbbi Terminoloji
dc.subjectTıbbi Sekreterlik ve Transkripsiyon
dc.subjectSağlık Bilgi Yönetimi
dc.subjectSağlık Meslekleri (çeşitli)
dc.subjectGenel Sağlık Meslekleri
dc.subjectPatofizyoloji
dc.subjectBakım Planlaması
dc.subjectDeğerlendirme ve Teşhis
dc.subjectDahiliye
dc.subjectSağlık Politikaları
dc.subjectAile Sağlığı
dc.subjectTıp (çeşitli)
dc.subjectGenel Tıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectSAĞLIK BAKIM BİLİMLERİ VE HİZMETLERİ
dc.subjectGözden Geçirme ve Sınav Hazırlığı
dc.subjectLiderlik ve Yönetim
dc.subjectTemel Bilgi ve Beceriler
dc.subjectToplum Sağlığı ve Evde Bakım
dc.subjectAile Hekimliği
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectTIP, GENEL & DAHİLİ
dc.titleDid the ERAS Protocol Improve Our Results in Locally Advanced Gastric Cancer Surgery?
dc.typeMakale
dc.relation.journalJOURNAL OF PERSONALIZED MEDICINE
dc.contributor.departmentUniv Hlth Sci , ,
dc.identifier.volume12
dc.identifier.issue10
dc.contributor.firstauthorID4073149


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster